sepimostate mesilate has been researched along with Gastritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanno, K; Makuuchi, H; Mitomi, T | 1 |
| Fujimoto, N; Furukawa, H; Hiratsuka, M; Imamoto, H; Imaoka, M; Inoue, M; Iwanaga, T; Kawasaki, T; Kikkawa, N; Kobayashi, K; Mori, T; Noguchi, S; Ogawa, Y; Okamura, J; Okuda, H; Oshima, S; Satomi, T; Shiozaki, H; Takada, N; Takada, T; Takami, M; Tamura, S; Yamada, T; Yamasaki, K; Yano, T | 1 |
2 trial(s) available for sepimostate mesilate and Gastritis
| Article | Year |
|---|---|
[Clinical usefulness of FUT-187 (sepimostat mesilate) on reflux esophagitis and gastritis after gastrectomy].
Topics: Administration, Oral; Aged; Esophagitis, Peptic; Female; Gastritis; Humans; Imidazoles; Male; Middle Aged; Postgastrectomy Syndromes; Stomach Neoplasms; Stomach Ulcer | 1995 |
[Effect of FUT-187, oral serine protease inhibitor, on inflammation in the gastric remnant].
Topics: Administration, Oral; Adult; Aged; Gastrectomy; Gastric Stump; Gastritis; Humans; Imidazoles; Middle Aged; Postoperative Complications; Protease Inhibitors | 1996 |